Skip to main content
Clinical Trials/NCT06052605
NCT06052605RecruitingNot Applicable

Healthy Aging in People With Epilepsy Program (HAP-E): Closing the Gap in Epilepsy Care

Anny Reyes2 sites in 1 country380 target enrollmentStarted: March 25, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Anny Reyes
Enrollment
380
Locations
2
Primary Endpoint
Health literacy

Study Overview

Brief Summary

The goal of this clinical trial is to develop and test an educational program about dementia in older adults living with epilepsy. The main questions it aims to answer are:

  1. Can providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors improve dementia knowledge and health literacy among older adults with epilepsy?
  2. Can aging related education and resources improve quality of life among older adults with epilepsy?

Participants will:

  • Be randomized to an intervention group or a control group.
  • Complete a 12-week group educational program (intervention group).
  • Complete pre- and post-program evaluation (intervention and control groups).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
55 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Part 1a - Patient Survey:
  • Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
  • Age 55 years or older
  • Proficiency in English (self-assessed)
  • Part 1b - Provider Survey:
  • Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy (including Epilepsy Foundation organizational leaders)
  • Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
  • Age 55 years or older (up to 90)
  • Proficiency in English (self-assessed)

Exclusion Criteria

  • Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
  • Age 90 years or older
  • Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
  • Age 90 years or older

Arms & Interventions

Part 1a: Patient Survey

Other

Patients with receive an online survey to identify barriers in accessing geriatric care, target educational topics, and concerns about aging. Additionally, they will be surveyed on unmet needs in their care, availability of healthcare information and resources related to aging and dementia, and elements of the program most important to them.

Intervention: Patient Survey (Other)

Part 1b: Provider Survey

Other

Providers will receive an online survey to identify barriers in accessing geriatric care, target educational topics, and concerns about aging.

Intervention: Provider Survey (Other)

Part 3: Intervention

Experimental

Participants randomized to this group will receive a 12-week group educational program (either virtual or in-person based on patient preference) providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors.

Intervention: Healthy Aging in People with Epilepsy Program (Behavioral)

Part 3: Control

No Intervention

Participants randomized to this group will receive standard care during their participation

Outcomes

Primary Outcomes

Health literacy

Time Frame: Pre and Post intervention (3 months)

Short Assessment of Health Literacy-English is an 18-item scale assessing adult's ability to read and understand common medical terms.

Health Related Quality of life

Time Frame: Pre and Post intervention (3 months)

Quality of life in Epilepsy-31 is a self-report questionnaire assessing quality of life in individuals with epilepsy. It measures of overall quality of life, emotional well-being, role limitations due to emotional problems, social support, social isolation, energy/fatigue, worry about seizure, medication effects, health discouragement, work/driving/social function, physical function, pain, role limitations due to physical problems, health perception, and perceived problems with attention/concentration, language, memory.

Dementia Knowledge

Time Frame: Pre and Post intervention (3 months)

Dementia Knowledge Assessment Tool was designed to measure change in knowledge of dementia including dementia and its progress, support, and care. It contains 21 true/false items.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Anny Reyes
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Anny Reyes

Associate Staff, Principal Investigator

The Cleveland Clinic

Study Sites (2)

Loading locations...

Similar Trials